3:00 PM                Registration

4:00 - 4:30            Welcome and Overview of Program

Phyllis Tien, MD - University of California, San Francisco
Kenneth E. Sherman, MD, PhD 

Session 1            HIV and Liver Disease: The Evolving Landscape

Moderator: Kenneth Sherman, MD, PhD 

4:30 – 5:00            Breaking News in HIV

5:00 – 5:30            Hot Topics in Liver Disease in 2025: HIV Considerations

5:30 – 6:00            HCC in HIV: An Emerging Threat

6:00 – 6:45            Panel Discussion

6:45 – 7:00            Break

7:00 – 9:00            Poster Reception (all poster presenters at posters)

Friday, September 26
(agenda subject to change)

7:30 - 8:00 AM      Continental Breakfast

Session 2             Emerging Issues in Metabolic Dysfunction Associated Steatotic Liver Disease in HIV

Moderator:  Phyllis Tien, MD 

8:00 - 8:30             Steatotic Liver Disease: What does it mean for PWH?

8:30 – 9:00            Adipocyte Function and MASLD

9:00 – 9:30            Omic Approaches to Understanding MASLD

9:30 - 9:45            Selected Abstract

9:45 - 10:00          Selected Abstract

10:00 - 10:15        Panel Discussion

10:15 - 10:45        Break

Session 3            Advances in HBV Testing, Prevention, and Treatment

Moderator: David Thomas, MD

10:45 – 11:15        HBV DNA Reservoirs and Achieving HBV Cure

11:15 – 11:45        Immune and Non-Immune Targets of HBV:                                                                                                               Does Single or Combination Therapy Make Sense?

11:45 – 12:15       HBV Prevention in the Era of LA HIV Therapies

12:15 – 12:30       Selected Abstract

12:45 – 1:00         Move to Small Group Area

1:00 – 2:30           Lunch (MASLD/MASH Therapeutics)
 

Saturday, September 27
(agenda subject to change)

7:30 - 8:00 AM      Continental Breakfast

Session 4           Emerging Issues in Viral Hepatitis from C to E and Advances in Prevention and                                              Treatment

Moderator: Kenneth E. Sherman, MD, PhD 

8:00 - 8:30            Long-Acting HCV Therapies

8:30 - 9:00            Updates in Hepatitis E Virus

9:00 - 9:30            Hepatitis C Prevention

9:30 - 9:45            Selected Abstract 

9:45 - 10:00          Panel Discussion

10:00 - 10:30        Break

Session 5             Trends in Alcohol, Drugs, and Polysubstance Use and Impacts on HIV and Viral                                            Hepatitis Infections

Moderator: Phyllis Tien, MD 

10:30 - 11:00         Unhealthy Alcohol Use Among Patients in HIV: Can We Change the Outcome?

11:00 - 11:30         Emerging Issues in Substance Use in the US: Impacts on HIV and Viral Hepatitis

11:30 - 12:00         Managing the Opioid Epidemic

12:00 - 12:15         Selected Abstract 

12:15 - 12:30         Panel Discussion

Session 6            Research Agenda - Plans for the Next Two Years

Moderator: Kenneth E. Sherman

12:30 - 1:00          Summary of Key Research Agenda/Plans for the Next 2 Years

1:00 - 1:15            Conference Wrap-Up